Notice_of_Intent-_Copyright_Clearance_Center_-_1145742.pdf

Notice of Intent – FDA – Copyright Clearance Center (CCC) Copyright Clearance Database – Web-based Annual License

DATE: April 21, 2015

REQUISITION NUMBER: 1145742

PLACE OF PERFORMANCE: Silver Spring, MD

NAICS CODE: 533110

The U.S. Food and Drug Administration, Silver Spring, MD intends to award a firm-fixed price contract for

(1) Web-based Copyright Clearance Database annual license, to Copyright Clearance Center (CCC) at 222 Rosewood Drive, Danvers, MA 01923. There are no set-aside restrictions for this procurement, and date of delivery is anticipated to be July, 2015. Copyright Clearance Center offers a product with capabilities that are not available from any other vendor:

1. The FDA Library currently operates a Document Delivery System which provides scanned copies of requested scientific journal articles to FDA staff. The copyright enforcement of these articles is done manually by FDA Library staff. The FDA has an ongoing business need to obtain a solution that will automate this process.

2. The Copyright Clearance Center (CCC) operates a database in which businesses and academic institutions may obtain permission to share copyright-protected materials. On the back-end of this process, the publishers and creators of these copyright-protected works are automatically compensated for the use of these materials. Copyright Clearance Database access would alleviate FDA Library staff from performing these tasks.

3. Copyright Clearance Database licenses are not available via GSA Schedule, as was confirmed by

CCC.

4. Contract Specialist was provided a signed letter from CCC, stating that it is the only vendor that can provide the licenses to the database. Market research confirmed that CCC is the only responsible source for a Copyright Clearance Database license. CCC confirmed that they do not have authorized resellers with the ability to provide this license on behalf of CCC.

5. Market research has produced several vendors which will copyright materials. However, CCC is the only vendor shown to provide copyright clearance services for published material distribution purposes. CCC is also the only operational database service that compensates publishers and creators on the back-end.

The Government intends to solicit and negotiate with only one source under authority of FAR 6.302-1.

Interested entities may identify their interest and capability to respond to the requirement or submit proposals. This notice is not a request for proposal and a solicitation will not be issued in conjunction with the notice of intent. Any vendor that believes it can provide the stated supplies/equipment can provide supporting documents demonstrating their products capability and specifications statement. The FDA will review all responses received; however, the Government retains the sole discretion not to further compete the proposed acquisition based on responses to this notice. Information can be sent to Kyle Smith at Kyle.Smith@fda.hhs.gov. No telephone or facsimile requests will be accepted.